NAUT · Nautilus Biotechnology, Inc. · Metrics
$2.31
-0.02 (-0.65%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$295.50M
Shares
127.37M
Volume · Nov 16
1.75M
Avg daily vol (3M)
5.87M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
NAUT metrics
65 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$2.32
Market cap
$295.50M
Price action
23 metricsPrice change (1W)
+4.0%
Price change (30D)
+12.6%
Price change (3M)
+160.1%
Price change (6M)
-7.6%
Price change (YTD)
+19.0%
Price change (1Y)
+22.8%
Trailing year
Price change (5Y)
-55.3%
52-week high
$3.95
52-week low
$0.85
Change from 52-week high
-41.3%
Change from 52-week low
+172.4%
Annualized volatility
117.1%
Annualized volatility (3M)
158.4%
Implied volatility (30D)
144.6%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.5
RSI (14D)
50.6
Price vs SMA 50
+24.0%
Price vs SMA 200
+8.9%
Avg volume (3M)
5.87M
Relative volume
0.3
Average dollar volume
$12.67M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
127.37M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.5
reciprocal yield 39.4%
FCF yield
-18.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-10-27
Profitability
9 metricsGross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
−$58.58M
Trailing 12 months
Diluted EPS (TTM)
$-0.46
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-50.3%
Return on assets
-39.3%
Debt / equity
—
Current ratio
9.2
EBITDA (TTM)
—
Free cash flow (TTM)
−$55.13M
Quick ratio
9.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$10.47M
Latest balance sheet
Cash & equivalents
$10.47M
Total assets
$148.92M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$52.48M
Capital expenditures (TTM)
$2.65M
R&D (TTM)
$39.07M
SG&A (TTM)
—
Stock compensation (TTM)
$5.28M
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
93
13F filer change QoQ
+12
Institutional ownership
39.4%
Conviction holders (share of 13F filers)
1.1%
Crowding (high-turnover and private-fund holders)
27.3%
Private-fund adviser ownership
26.2%
Active holders' share change QoQ
-16.4%
Holder tenure
12.9
Price vs estimated holder cost
-65.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
4.0%
Short interest
3 metricsShort interest
4.6%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
56 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1808805
CUSIP
63909J108
13F (30d)
65 filings
54 filers
Visit website
Investor relations